People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| J3 Bioscience, Inc. | — | Biotech | Seed | $5.5M | $7.4M | 2022 |
Stath J. Karras at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stath J. Karras on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Larry D. Rigby | 1 | 2 |
| Duck Joo Lee | 1 | 1 |
| R. Tyler McCabe | 1 | 1 |
| James E. Herrin | 1 | 1 |
| Tim S. Glassett | 1 | 1 |
| Keith A. Marmer | 1 | 1 |
| John S. Fair | 1 | 1 |
| Ron E. Nielsen | 1 | 1 |
| Stephanie A. Singer | 1 | 1 |
| Troy E. Mason | 1 | 1 |
| Sheryl A. Kingsberg | 1 | 1 |
| Jayne F, Carney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.